Hugh Watson

Hyponatremia in cirrhosis: Results of a patient population survey

Paolo Angeli, Florence Wong, Hugh Watson et al. · Hepatology · 2006 · 435 citations · Full text

South America, Renal Function, Hepatology +9

Effects of satavaptan, a selective vasopressin V2 receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia

Pere Ginès, Florence Wong, Hugh Watson et al. · Hepatology · 2008 · 193 citations · Full text

Proton pump inhibitors as a risk factor for hepatic encephalopathy and spontaneous bacterial peritonitis in patients with cirrhosis with ascites

Gitte Dam, Hendrik Vilstrup, Hugh Watson et al. · Hepatology · 2016 · 185 citations

Factors related to quality of life in patients with cirrhosis and ascites: Relevance of serum sodium concentration and leg edema

Elsa Solà, Hugh Watson, Isabel Graupera et al. · Journal of Hepatology · 2012 · 139 citations

Leg Edema, Renal Function, Hepatology +6

Satavaptan for the management of ascites in cirrhosis: efficacy and safety across the spectrum of ascites severity

Florence Wong, Hugh Watson, Alexander L. Gerbes et al. · Gut · 2011 · 126 citations